Wakefield Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$568K	Hold	1,276	–	–	0.16%	154
2025 Q1	$619K	Buy	+1,276	New	+$619K	0.19%	144
2022 Q2	–	Sell	-11,689	Closed	-$3.05M	–	210
2022 Q1	$3.05M	Buy	+11,689	New	+$3.05M	1.09%	24